Gujarat Terce Laboratories share news and announcements
BSE: 524314Pharmaceuticals & BiotechnologySmall Cap
Last close ₹34.13down ₹2.78 (7.53%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹36.91.
52-week range of traded prices to 23 Oct 2026
₹29.00Low, 30 Mar 2026₹53.49High, 23 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹27 Cr3,856th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 7 Aug 2026
- 12.7
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹0.45 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 10.5
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 30 May 2026
- 2.7
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 7 Aug 2026
- 25.8%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹0.45 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 31.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 7 Aug 2026
- 25.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 30 May 2026
- 0.13
- Volume, BSEVolume. Shares traded on the last trading day.
- 3,356
Gujarat Terce Laboratories board meetings
118 filed, newest first. Page 1 of 3.
Aug 2026
3 Aug · Board meeting
Meeting on 7 Aug 2026: quarterly results
May 2026
13 May · Board meeting
Meeting on 29 May 2026: annual general meeting and audited results
Dec 2025
29 Dec · Board meeting
Meeting on 4 Feb 2026: quarterly results
Nov 2025
3 Nov · Board meeting
Meeting on 8 Nov 2025: quarterly results
Sep 2025
1 Sep · Board meeting
Aug 2025
4 Aug · Board meeting
Meeting on 11 Aug 2025: quarterly results
Jul 2025
17 Jul · Board meeting
9 Jul · Board meeting
Meeting on 17 Jul 2025: annual general meeting
May 2025
26 May · Board meeting
19 May · Board meeting
Meeting on 26 May 2025: audited results
Jan 2025
27 Jan · Board meeting
Meeting on 4 Feb 2025: quarterly results
Oct 2024
18 Oct · Board meeting
Meeting on 28 Oct 2024: annual general meeting and quarterly results
Aug 2024
9 Aug · Board meeting
2 Aug · Board meeting
Meeting on 9 Aug 2024: annual general meeting and quarterly results
May 2024
29 May · Board meeting
29 May · Board meeting
21 May · Board meeting
Meeting on 29 May 2024: audited results
Mar 2024
22 Mar · Board meeting
Meeting on 29 Mar 2024: preferential issue of shares
Feb 2024
Jan 2024
23 Jan · Board meeting
Meeting on 5 Feb 2024: quarterly results
Nov 2023
Oct 2023
31 Oct · Board meeting
Meeting on 8 Nov 2023: quarterly results
Jul 2023
21 Jul · Board meeting
Meeting on 11 Aug 2023: quarterly results
May 2023
4 May · Board meeting
Meeting on 13 May 2023: audited results
Jan 2023
31 Jan · Board meeting
25 Jan · Board meeting
Meeting on 31 Jan 2023: quarterly results
Nov 2022
14 Nov · Board meeting
3 Nov · Board meeting
Meeting on 14 Nov 2022: quarterly results